Clinical Trials

Since our founding in 2000, Retina Consultants of Charleston’s mission has been to provide excellence in patient care for eye disease and education of eye care providers and patients. To maintain excellence, research must be an integral part of this mission.

Phase 4 NO SHAM ARM Study – Clinical Trial

Retina Consultants of Charleston, Clinical Trials Division
Now Accepting Patients: Phase 4 Study, NO SHAM ARM.
Looking for Rigorous Evaluation of Vision and Safety after treatment with EYLEA.
Clinical Trial Inclusion Criteria:
1. Naive patients with unilateral wet AMD.
2. VA 20/40 to 20/320
3. Men or women 50 years of age or older.
Clinical Trial Exclusion Criteria:
1. Wet AMD in the fellow eye. If after enrollment the patient developes wet AMD in the fellow eye, EYLEA will be provided for free for that eye.

Participants will receive study-related care at no cost for the duration of the study.


Call our office for details, or visit us on the web to make a patient referral.

(843) 763-4466

Clinical Trials in both Wet AMD & Dry AMD

We are the only practice in South Carolina offering Clinical Trials in both Wet AMD and Dry AMD.

We see patients for macular degeneration, macular holes, diabetic retinopathy, epiretinal membranes, retinal detachments, sickle cell disease, ocular complications, ocular trauma, uveitis, complications of cataract surgery, ocular tumors and neuro-opthalmology.

We accept new patient referrals by phone, fax, email, or online here.


By |November 7th, 2012|Categories: Clinical Trials, Retina||Comments Off on Clinical Trials in both Wet AMD & Dry AMD

Geographic Atrophy Clinical Trials

Now Accepting Patients for Geographic Atrophy Study!
Inclusion Criteria:
1. Patients with Geographic Atrophy in one or both eyes.
2. Visual Acuity 20/200 or better
3. Willing to participate in a clinical research program investigating a potential new therapy to treat geographic atrophy

Participants will receive study-related care and medication at no cost for the 18 month duration of the study

Call our office for details, or visit THIS PAGE to make a patient referral.

(843) 763-4466

National Diabetic Eye Disease Month

November is American Diabetes Month, and it is a time to raise awareness of diabetes prevention and control.  In conjunction with this National effort, November is also recognized as National Diabetic Eye Disease Month, and Retina Consultants of Charleston has been leading the fight against diabetic eye disease right here in the Lowcountry for over a decade.

There are many problems that people with diabetes face.  Diabetic eye disease is one of the more common complications, and all forms of diabetic eye disease may cause severe vision loss or blindness.

Diabetic eye disease may include:

Diabetic retinopathy—damage to the blood vessels in the retina.
Cataract—clouding of the eye’s lens. Cataracts develop at an earlier age in people with diabetes.
Glaucoma—increase in fluid pressure inside the eye that leads to optic nerve damage and loss of vision. A person with diabetes is nearly twice as likely to get glaucoma as other adults.

“For some patients, diabetic retinopathy is actually one of their first signs of having diabetes. The risk of developing a diabetic eye disease increases the longer a person has had diabetes, but some may develop retinal abnormalities within a year or two of the first appearance of the disease” says Dr. Virgil Alfaro, an Ophthalmologist and retina specialist with Retina Consultants of Charleston.

Because diabetic eye disease may be developing even when your sight is good, having regular dilated eye exams is very important for discovering issues early. Some patients may notice signs of vision changes. If you’re having trouble reading, if your vision is blurred, or if you’re seeing rings around lights, dark spots, or flashing lights, you may have eye problems. Be sure to tell our team about any eye problems you may have.

We proudly announce the publication of Macular Surgery, 2nd Edition!

Macular Surgery, Second Edition

is written for and by retina specialists. It details the surgical indications and surgical techniques in the management of macular diseases.  With the first edition published in 1999, this second book published in 2011 presents a highly illustrated treatise on surgical maneuvers and techniques.
This text serves as a comprehensive and contemporary analysis of macular diseases and their management.  An exhaustive review of the latest proven surgical techniques and therapies for treatment of macular disorders is provided, with emphasis on proven techniques from extended investigations of controlled clinical trials.

This book gives a good and advanced insight to macular diseases and surgery. It touches the sub-macular surgery techniques and macular translocation procedures quite nicely, and the summary of the ETDRS and MPS is also an excellent reference for retina fellows.  Want a copy for your practice?  Click Here!